MADOPAR HBS 125 CAPSULE
Product details
Registration number: SIN05195P
Classification: Prescription Only
Active ingredients:
- Benserazide HCl 28.5mg equivalent to benserazide
- LEVODOPA
Strength:
- 25 mg
- 100 mg
Dosage form: CAPSULE
Route: ORAL
Registrant: ROCHE SINGAPORE PTE. LTD.
ATC code: N04BA02
HSA approval date: 17 January 1990
Manufacturer(s): Delpharm Milano S.r.l
Manufacturing country/countries: ITALY
What are the HSA registration number and classification for MADOPAR HBS 125 CAPSULE?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN05195P
Classification: Prescription Only
What active ingredients and strength are recorded for MADOPAR HBS 125 CAPSULE?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- Benserazide HCl 28.5mg equivalent to benserazide
- LEVODOPA
Strength:
- 25 mg
- 100 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for MADOPAR HBS 125 CAPSULE?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE
Route: ORAL
Who is the recorded registrant for MADOPAR HBS 125 CAPSULE?
According to the HSA dataset updated 7 August 2026:
Registrant: ROCHE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for MADOPAR HBS 125 CAPSULE?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Delpharm Milano S.r.l
Manufacturing country/countries: ITALY
Where can I look up MADOPAR HBS 125 CAPSULE in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN05195P or the exact product name MADOPAR HBS 125 CAPSULE. The general register link does not preselect this product.
What are the source dates for this MADOPAR HBS 125 CAPSULE record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this MADOPAR HBS 125 CAPSULE record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN05195P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)